PSTV

Plus Therapeutics Inc (PSTV) receives a Buy rating from D. Boral Capital

Anna Perez

Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...

Plus Therapeutics Inc (PSTV) rating upgrades by D. Boral Capital

Anna Perez

In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...

An Analysis of Plus Therapeutics Inc (PSTV)’s Potential Price Growth

Samantha Gray

In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...

Investing in Plus Therapeutics Inc (PSTV): What You Must Know

Anna Perez

Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...

Plus Therapeutics Inc’s latest rating changes from various analysts

Jaxson Clark

In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.